Objective: to assess the efficacy and safety of the use of nebulized L-epinephrine associated with dexamethasone in postintubation laryngitis.
Introduction
Postintubation laryngitis (PIL) is still frequent in pediatric intensive care units (PICU), aggravating the clinical status of critically ill patients1. Prophylactic measures have been able to reduce the incidence of PIL through the optimization of the techniques used in the implementation and maintenance of endotracheal intubation. 1,2 Drug treatment with corticoids has also been used; however, results are still inconclusive. 3 Therefore, today, approximately 10 to 20% of intubated children manifest PIL while in the PICU, which is a crucial therapeutic problem. 2 The treatment is based on intravenous or inhaled corticosteroids, considered to be the most efficient drug for the treatment of PIL, and for humidified inspired oxygen therapy. [4] [5] [6] [7] [8] [9] Most cases of PIL evolve favorably under this therapeutic regimen; however, prolonged and intense cases still occur, and some cases develop into respiratory failure and reintubation. 2, 3 With the aim of optimizing the treatment of PIL, authors have tried to combine other drugs such as nebulized epinephrine. [10] [11] [12] [13] In terms of pharmacodynamics, there seems to be well-founded reasons for the combined use of corticosteroids and epinephrine. [10] [11] [12] Dexamethasone, when intravenously administered, exerts an antiinflammatory effect within 15 to 60 minutes, reaching maximum effect after two hours. 3, 5 Nebulized epinephrine, in its turn, has immediate action, reaching its maximum effect within minutes. 10, 12 Therefore, epinephrine may optimize the treatment of PIL right after its diagnosis, when the clinical status is usually more intense. 14, 15 In addition, the different mechanism of therapeutic action of both drugs may result in a synergistic effect. 11, 16, 17 In clinical terms, the combined use of corticosteroids and racemic epinephrine seems to optimize therapeutic results. [14] [15] [16] [17] The available studies on L-epinephrine, which is more affordable and easily obtained, are not enough, and conclusions are not yet clearly established. [18] [19] In an attempt to contribute to therapeutic studies on PIL, the authors decided to evaluate the efficiency and occurrence of cardiocirculatory side effects caused by L-epinephrine when supplemented with intravenous dexamethasone.
Methods
The study was performed at the ICU of a university hospital in the district of Butantã, with approximately 500,000 inhabitants, from low socioeconomic level.
A prospective randomized double-blind study was carried out during a two-year period. The protocol was previously approved by the Ethics Committee, and Education and Research Committee of the Teaching Hospital of Universidade de São Paulo. An informed consent was signed by parents or guardians.
All the cases that met the following criteria were included in the study: a) individuals aged between 1 month and 14 years; b) tracheal intubation performed at the PICU; c) intubation for more than one day; d) diagnosis of postextubation laryngitis through the modified DownesRaphaelly score (FiO 2 =60%), including grades between 3 and 6 (Table 1) . 20 The exclusion criteria were the following: a) cases with confirmed congenital malformation of airways; b) use of vasoactive drugs on the day of extubation; c) use of corticosteroids within 48 hours prior to extubation.
The patients who participated in the study initiated the treatment (Ti) with intravenous dexamethasone (bolus dose) and were submitted to sequential, nonstop saline aerosol inhalations during 5 minutes. The L-epinephrine was diluted in saline solution for only one of the groups. The differences observed between the groups, during 24 hours, were attributed to the effect of L-epinephrine.
The stratification was carried out through computerized randomization -the Random mathematical function in MicrosoftR Excel 4.0. The group submitted to saline aerosol inhalation was called group A. The other group (group B) received aerosol inhalation of L-epinephrine diluted in saline.
Solutions A and B were prepared at the pharmacy of the university hospital, and an effort to maintain similar characteristics as to pH, odor and color, was made. The saline solution used in solution A received diluted 3N hydrochloric acid in order to reach a 2.5 pH value that was similar to that of the epinephrine solution (B). Solution B consisted of 5 mg of L-epinephrine diluted at 1/1000. Both solutions were placed in identical vials with a volume of 22.5 ml, wrapped in aluminum foil in order to prevent Lepinephrine precipitation. Only the pharmacist in charge of elaborating the substances and one member from the PICU staff, who did not belong to the study group, knew the formulation of solutions A and B during the protocol. This extra care was taken to safeguard a possible medical intervention in the event of side effects.
The clinical and laboratory assessments of the cases were more frequently monitored and more deeply analyzed during the first two hours of treatment (Ti). The first assessment was made after 5 minutes, at the end of inhalations, with notation T 5 . Subsequently, each case was evaluated every 30 minutes, from the beginning of therapy (Ti), denoted as T 30 , T 60 , T 90 and T 120 . Patients were monitored during 22 additional hours for the sole purpose 20 heart rate of heart rate and clinical score assessments. During this period, assessments were carried out every 2 hours. The protocol was interrupted under the following circumstances: a) if the score was greater than or equal to 8-which was considered a therapy failure and an indicative sign of reintubation; and b) 24 hours after Ti. The study layout is shown in Figure 1 .
All the patients studied were assessed by the author or other assistant doctor from the unit for selection of cases and follow-up during the protocol.
During the study, all extubated children were placed on acrylic tents with supplementation of humidified oxygen, with an inspired oxygen fraction of 60%. The cases of postintubation laryngitis were selected for the study and registered, receiving dexamethasone intravenously at 0.15 mg/kg, with repeated doses at intervals of six hours during five days. 7, 9 At the beginning of the protocol, patients were also submitted to two sequential inhalations of either solution A or B, with total duration around 10 minutes. The use of two sequential inhalations aimed at reducing possible epinephrine losses. The solution that should be used for each case conformed to the list previously established by randomization. 21 Evaluation criteriaHomogeneity of compared groups. The homogeneity of PIL intensity/severity in both groups was analyzed through the modified Downes-Raphaelly score 20 (Table 1) at T 0 . Other variables, regarded as secondary, were also registered for the comparison between the groups, and namely are: a) children's ages; b) gender; c) weight; d) intubation attempts (number of times that the laryngoscope was inserted into the oropharynx as an attempt to intubate the patient); e) duration of endotracheal intubation (period during which the patient remained intubated); f) interval between extubation and detection of laryngitis; g) diameter of the cannula (size of the endotracheal cannula, in millimeters); h) type of physician who performed the intubation (resident, pediatrician or anesthetist); i) respiratory frequency at To; j) arterial saturation of oxygen at T 0 .
To determine the side effects of L-epinephrine, the homogeneity of both groups A and B in terms of heart rate and average blood pressure at To was analyzed.
Therapeutic efficiency of nebulized L-epinephrine on PIL.
The modified Downes-Raphaelly score 20 was used as a comparison parameter ( Table 1 ). The mean clinical evolution scores of both groups were compared at instants T 5 ,T 30 , T 60 , T 90 and T 120 of the protocol. The individual scores observed during the 24 hours of the protocol gave rise to the category called therapeutic failure -Downes-Raphaelly score greater than 7. The therapeutic failure rates of both groups were compared.
The effect of L-epinephrine on respiratory frequency and arterial blood gas levels.
Additionally, the respiratory frequency of both groups, and also the saturation of arterial blood oxygen via saturation meter, saturation of arterial blood oxygen via gas analysis, and partial arterial blood oxygen and carbon dioxide pressures, were compared.
At instants T 5 T 30 , T 60 , T 90 and T 120 of the protocol, saturation levels were measured by a Space LabsR pulse oximeter. Arterial blood gas analyses were obtained at instants T 30 and T 90 . The respiratory frequencies were compared at instants T 30 and T 90 .
Side effects of nebulized L-epinephrine.
Three parameters were comparatively assessed in groups A and B, with the aim of identifying possible side effects of L-epinephrine: heart rhythm, heart rate, and average blood pressure. The three parameters were assessed at instants T 5 , T 30 , T 60 , T 90 and T 120 . In the subsequent 22 hours, the levels of cardiac arrhythmia were compared. Heart rhythm was monitored by the Space LabsR equipment , and average blood pressure was recorded by the noninvasive DixtalR monitor.
It was previously agreed that the following side effects would be considered as a result from the use of L-epinephrine: a great number of children with cardiac arrhythmia in group B, and increased heart rate and blood pressure means in comparison with group A.
The statistical analysis made use of the following tests and techniques. 21 Fisher's exact test, Kruskal-Wallis test, Student-t test, Bonferroni's test, covariance among repeated measurements; analysis of variance among repeated measurements; BMDP applications (module 2V); Minitab for Windows and SPSS for Windows. For the determination of matrices, the following tests were used: test for matrix equality and sphericity test.
Results
From July 1993 to June 1995, 816 patients were admitted to the intensive care unit. No laryngeal complications were observed on admission. Among inpatients, 289 (35.4%) were submitted to intubation, and 42 (14.5%) of these presented with PIL. All of these cases met the selection criteria and were referred to the therapeutic protocol. One child from group A (saline solution) was excluded from the study for not undergoing the established assessments at instant T 30 , due to the simultaneous occurrence of another ICU emergency. Therefore, the 41 cases in the study sample were distributed according to randomization into 22 patients for group A (saline solution), and 19 patients for group B (saline solution + L-epinephrine). The clinical characteristics of both groups are shown in Table 2 .
As far as the homogeneity of both groups was concerned, there was no significant difference as to the intensity of PIL, assessed through the clinical score (P=0.07). The other characteristics of both groups, which were considered secondary variables in the homogeneity analysis, were, in general, similar (Table 2) . It is important to emphasize that patients in group B (in which epinephrine was used later), remained intubated for a longer period (P=0.03), and had higher respiratory frequency at the time of extubation (P=0.03) ( Table 2 ). Analyses to check the possible interference of these secondary variables with protocol results (instants T 5 , T 30 , T 60 , T 90 and T 120 ) were performed. The covariance among repeated measurements was used. Variables of interest included the means for clinical score, heart rate, arterial blood pressure, and oxygen saturation (saturation measurement), regarded as outcome measure. The saline and L-epinephrine solutions were used as explanatory variables; the covariables included the number of intubation attempts, and the duration of endotracheal intubation. Based on this analysis, we concluded that the duration of endotracheal intubation and the number of intubation attempts were not significant for the explanation of any of the variables of interest, allowing the comparison between the groups. The clinical statuses of children in groups A and B were considered acute and similar at the diagnosis of PIL, except for one child in group B, who had chronic renal infection after nephrectomy. The main diagnoses on admission for groups A and B were respectively lower respiratory tract infection (16 and 16); systemic infection (7 and 8); nonrespiratory infection (3 and 4) ; central nervous system disorders (5 and 4); and hemodynamic instability (6 and 5). One of the cases included postoperative complications (mentioned above); however, no cases presented with burns, accidents, or exogenous intoxication.
Three cases in group A showed a Downes-Raphaelly score of 8, were considered therapeutic failures, and were reintubated at instants T 30 , T 30 and T 60 of the protocol. No case occurred after T 60 , within the 24 hours of protocol, and no reintubation was performed, for any other reason. For the remaining 38 cases of PIL in groups A and B, there was a gradual improvement of the clinical status within the first two hours of the protocol, assessed through evolutional scores. The Downes-Raphaelly evolution scores of the 38 cases in groups A and B who completed the protocol are respectively shown in Table 3 and Table 4 .
The average scores observed at T 5 , T 30 ,T 60 ,T 90 and T 120 for the 19 cases in each group, A and B, are shown in Table 5 . In both groups, the average scores, when compared through Bonferroni's test, show significant and progressive reduction within the first two hours of the protocol (P<0.001). T i -beginning of protocol T 5 -end of inhalations T N -moment of the protocol * Cases in which the protocol was discontinued due to reintubation needs T i -Beginning of protocol T 5 -end of inhalations T N -moment of the protocol
The clinical score was used to assess therapeutic failure and the evolution throughout the protocol. Three cases (13.6%) of therapeutic failure (score > 7), with subsequent reintubation, were observed among the 22 children in group A (saline solution), while no therapeutic failure was found among the 19 children in group B (P=0.14). In the assessment through the clinical evolution score, the 38 patients who completed the proposed evaluation period were considered. By excluding reintubated patients, we have 19 patients in the group treated with L-epinephrine (B) and 19 patients in the control group (A). Group B had average DownesRaphaelly scores lower than those presented by the control group, after the completion of second inhalation (Table 5) ; however, at all compared instants, the results were not statistically significant. The boxplot of the scores is shown in Figure 2 .
Side effects in group B (L-epinephrine).
No episode of cardiac arrhythmia was observed through continuous monitoring during the protocol, or within the two hours after protocol completion. Table 5 shows the results of mean evolution heart rates for groups A and B. Heart rate was not statistically different during the protocol for either of the groups. The average arterial blood pressure was lower in group B at T 60 , a tendency that can be numerically observed at the subsequent instants of the protocol (Table 5) .
The results of respiratory frequency and blood gas analyses during the protocol for groups A and B are shown in Table 5 . The respiratory frequency of group B patients (L-epinephrine) was, on average, greater than that of group A patients; however, no significant differences were observed. It is important to point out that the respiratory frequency of group B patients was already greater at the beginning of the protocol, before the implementation of different therapeutic regimens ( Table 2 ). The results of evolutional gas analysis parameters were poorer for group B through saturation measurements and gas analyses within the first two hours of the protocol (Table 5) .
Discussion

a) Efficiency of L-epinephrine
The combination of L-epinephrine and dexamethasone did not show a significantly better therapeutic result than the isolated use of dexamethasone in the treatment of PIL. The result obtained is similar to that of some studies that also failed to show a clear advantage of combination therapy over the isolated use of dexamethasone. 5, 14, 22 Nonetheless, this unfavorable conclusion is not unanimous and should be carefully analyzed. 23 In the present study, there is some evidence that there might be a better therapeutic response through combination therapy when the results and characteristics of the protocol are collectively analyzed.
In terms of results, only the control group presented a score that indicates therapeutic failure and necessity for reintubation; however, the three cases could not be statistically confirmed (P=0.14). 16, 18, 22 From another standpoint, a more favorable tendency towards the evolution of PIL may be observed in group B through the average clinical scores obtained during the protocol (Table 5 and Figure 2) . A lower average score was found in group B at all evolution instants, although each isolated evaluation does not show statistical significance.
As to the experiment carried out, we should be aware that the small-sized sample used is a limiting factor to the statistical confirmation of therapeutic advantages, especially those that have little impact. The limited number of patients was due to low hospital admission rates during our study, which ended up originating some difficulty similar to that reported by other authors, who were not able to statistically show the clinical advantages of combination therapy. 18, 19 A minimal of 36 cases in group B would be necessary so as to show significance in terms of reintubation rates. In relation to the sample, the clinical homogeneity of groups A and B should be observed. There was a casual distribution of patients with poorer clinical profile in group B (Lepinephrine) ( Table 2 ). In this group, patients had a longer intubation period (P=0.03) and, at the diagnosis of PIL, the clinical score tended towards a higher value, although it did not reveal any discrepancy (P=0.07). Likewise, respiratory frequency had higher values (P=0.03).
The use of nebulized epinephrine in a group of patients with poorer clinical profile of PIL (group B) seems satisfactory since it has yielded results with a favorable tendency when compared to the control group ( Table 2) . As to other characteristics of the present study with possible implications for therapeutic results, we should pay special attention to three aspects of PIL in the assessed casesintensity of PIL, type of laryngitis, and nosological profile of the children. As to the intensity of selected cases of PIL, the criterion used in the present study (high clinical score) is similar to that found in the literature, identifying the most severe cases, in which therapy still needs improving. 4, [12] [13] [14] [16] [17] [18] [19] 22, [24] [25] [26] he type of laryngeal injury, discussed in the present study, could not be specified. Endoscopic examinations were only performed in the three cases that were submitted to reintubation. These patients had hyperemia, and prominent mucosal edema -frequent aspects of PIL. Some other lesions may be associated with the clinical diagnosis of PIL: ulcers, granulomas, vocal cord paralysis, synechia, subglottic stenosis, and also tracheal stenosis. 1, 2, 26 These laryngeal and upper tracheal complications may evolve and/or have therapeutic response different from most clinically recognized cases of PIL. 1, 2, 26 Actually, the endoscopic examination of the larynx would be more appropriate for the selection of PIL cases, allowing us to compare therapeutic results in a more adequate manner; 2,27 however, endoscopy has only been recommended for the cases that do not respond to therapy, in which behavior may be altered. 1, 2 In terms of the nosological profile of patients with PIL in the present study, there are some physiopathological aspects that could occasionally interfere with therapeutic results and which have been given little importance by the pertinent literature. The patients in the present series and in several other series have previous extensive systemic infections and/or lower airway infection, in addition to profusion disorders/tissue oxygenation and trophic alterations. It is not possible to assess the level of interference of these factors in the pathogenesis of PIL and in the response to the used medication. Nevertheless, we understand that the therapeutic results of the present experiment should be preferably compared to others that evaluate PIL in groups of children with similar severity and clinical characteristics. 12, 14, 26, 28 The rest of the study does not seem to present other characteristics that might interfere with the conclusions on the efficiency of L-epinephrine. We used the most commonly recommended doses of dexamethasone (0.6 mg/kg/day). 24, 36 Other authors suggest higher or lower doses without observing therapeutic advantages. 7, 14 The L-epinephrine dose (5 mg) was also suggested in other studies. 18, 19 All children who participated in this protocol were submitted to saline aerosol inhalation and oxygen therapy during the protocol. This procedure is recommended after extubation although it has limited effect on severe PIL. 11, 14 It is also important to emphasize that the efficiency of L-epinephrine on PIL was assessed in the present study as a supplementary drug to the acclaimed resources for therapeutic support.
b) Side effects associated with the use of L-epinephrine
were not observed as far as the analyzed parameters are concerned: arrhythmia, increased heart rate and increased average blood pressure (Table 5) . 15, 18, 29, 30 In general, the studies cited in the literature do not show significant side effects, although adrenergics are known as potential triggering mechanisms of cardiac arrhythmia, especially in cases of hypoxia, which may occur in PIL. 18, 19, 29 The recent publication of an isolated case of myocardial infarction caused by the use of racemic epinephrine has intensified the concern with this drug. 30 Interestingly, group B, which received L-epinephrine, had poorer blood gas values than the control group, although the values were within acceptable levels (Table 5 ). This aspect may indicate notable pulmonary and systemic actions of the drug and may be a clinical problem to some patients. 29 From a different angle, it is possible that the groups present several forms of lower airway involvement. The usual recommendation for blood gas analysis postextubation should be reinforced in patients who are using L-epinephrine.
We have observed through a group of children treated at the PICU of the university hospital that PIL is still a frequent problem. The acclaimed use of dexamethasone and humidified oxygen was not sufficient to avoid reintubation in three children, thus proving the necessity for the development of new therapeutic regimens. Therapeutic efforts should especially focus on the first hours after extubation, when PIL is more intense. Through the results obtained in the present study and also in previous studies, it is possible to perceive that nebulized L-epinephrine may have a negligible or absent role for most children with PIL when simultaneously used with dexamethasone. However, there is as yet unconfirmed evidence that a few patients may benefit from additional therapy with L-epinephrine. No significant side effects of L-epinephrine were observed. In general, conclusions were influenced by the reduced sample size, obtained from a single hospital, suggesting that a multicenter study is necessary so that persistent doubts may be cleared up.
